Cargando…

The curative effects of radiotherapy-based therapies for human epidermal growth factor receptor 2-positive breast cancer: A meta-analysis

AIM: This meta-analysis was designed to fully assess the curative effects of radiotherapy-based therapies for human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC). METHODS: English articles were retrieved through searching Cochrane library, PubMed, and Embase databases update...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Minghai, Zhang, Chi, Qin, Qin, Zhang, Zhaoyue, Zhu, Hongcheng, Di, Xiaoke, Sun, Xinchen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617696/ https://www.ncbi.nlm.nih.gov/pubmed/28930829 http://dx.doi.org/10.1097/MD.0000000000007946

Ejemplares similares

Endocrine therapies in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative, pretreated, advanced breast cancer: A network meta-analysis
por: Lee, Cho-Hao, et al.
Publicado: (2020)

Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case report
por: Dai, Jiali, et al.
Publicado: (2020)

Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment
por: Watanuki, Rurina, et al.
Publicado: (2020)

A phase I study of pharmacokinetics of trastuzumab emtansine in Chinese patients with locally advanced inoperable or metastatic human epidermal growth factor receptor 2-positive breast cancer who have received prior trastuzumab-based therapy
por: Ji, Dongmei, et al.
Publicado: (2020)

Association between depressive disorders and risk of breast cancer recurrence after curative surgery
por: Chen, Shaw-Ji, et al.
Publicado: (2016)

Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy
por: Cao, Lu, et al.
Publicado: (2016)

Pathological complete response to neoadjuvant trastuzumab and pertuzumab therapy is related to human epidermal growth factor receptor 2 (HER2) amplification level in HER2-amplified breast cancer
por: Choi, Jin Hyuk, et al.
Publicado: (2020)

Adjuvant ovarian suppression for premenopausal hormone receptor-positive breast cancer: A network meta-analysis
por: Jiang, Mengjie, et al.
Publicado: (2021)

Neoadjuvant chemotherapy combined with endocrine therapy for hormone receptor-positive breast cancer: A systematic review and meta-analysis
por: Ma, Hong-Fang, et al.
Publicado: (2023)

Vitamin D Receptor Polymorphism and Breast Cancer Risk: A Meta-Analysis
por: Lu, Demin, et al.
Publicado: (2016)

A comparison study between gross tumor volumes defined by preoperative magnetic resonance imaging, postoperative specimens, and tumor bed for radiotherapy after breast-conserving surgery
por: Zhang, Aiping, et al.
Publicado: (2017)

Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy
por: Li, Jin-luan, et al.
Publicado: (2017)

Positive estrogen receptor status is a poor prognostic factor in node-negative breast cancer: An observational study in Asian patients
por: Jung, Eun Jung, et al.
Publicado: (2021)

Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case report
por: Barchiesi, Giacomo, et al.
Publicado: (2019)

Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis
por: Ding, Yunfeng, et al.
Publicado: (2021)

Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis
por: Zhang, Yingzi, et al.
Publicado: (2020)

Correlation between rs13347 polymorphism of CD44 gene and the risk of occurring breast cancer: A protocol for systematic review and meta-analysis
por: Shao, Zilong, et al.
Publicado: (2021)

Comparison of rigid and deformable registration through the respiratory phases of four-dimensional computed tomography image data sets for radiotherapy after breast-conserving surgery
por: Zhang, Aiping, et al.
Publicado: (2017)

Concomitant fulvestrant with reirradiation for unresectable locoregional recurrent estrogen receptor positive (ER+) breast cancer: A case report and narrative review
por: Ding, Jingxian, et al.
Publicado: (2020)

Effect of evidence-based nursing intervention on upper limb function in postoperative radiotherapy patients with breast cancer
por: Wang, Xin, et al.
Publicado: (2020)

Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis
por: Lin, Yuxiang, et al.
Publicado: (2020)

Expression of hormone receptors in low-grade adenosquamous carcinoma of the breast: A case report
por: Wu, Hai-Bo, et al.
Publicado: (2017)

Diagnostic performance of mono-exponential DWI versus diffusion kurtosis imaging in breast lesions: A meta-analysis
por: Wang, Yewu, et al.
Publicado: (2022)

Prognostic nomogram for female patients suffering from non-metastatic Her2 positive breast cancer: A SEER-based study
por: Wu, Jiangwen, et al.
Publicado: (2022)

The value of different imaging methods in the diagnosis of breast cancer: A protocol for network meta-analysis of diagnostic test accuracy
por: Zhang, Mei, et al.
Publicado: (2021)

The relationship between exposure to particulate matter and breast cancer incidence and mortality: A meta-analysis
por: Zhang, Zhe, et al.
Publicado: (2019)

Effect of auricular point pressing therapy on hyperplasia of mammary glands: A protocol for systematic review and meta-analysis
por: Ma, Mengjie, et al.
Publicado: (2021)

Intervention for reducing anxiety during screening mammography: A protocol for systematic review and meta-analysis
por: Shang, Yi, et al.
Publicado: (2020)

Zolpidem-induced sneezing: A case report of positive rechallenge
por: Amraei, Razie, et al.
Publicado: (2018)

MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017)

Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis
por: Sheng, Zhijuan, et al.
Publicado: (2020)

Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis
por: Zhang, Shuo, et al.
Publicado: (2020)

Expression analysis of E-cad and vascular endothelial growth factor in triple-negative breast cancer patients of different ethnic groups in western China
por: Jiang, Weihua, et al.
Publicado: (2017)

Using a novel T-lymph node ratio model to evaluate the prognosis of nonmetastatic breast cancer patients who received preoperative radiotherapy followed by mastectomy: An observational study
por: Wang, Yang, et al.
Publicado: (2017)

Association between miR-27a rs895819 polymorphism and breast cancer susceptibility: Evidence based on 6118 cases and 7042 controls
por: Liu, Yuan, et al.
Publicado: (2021)

Methodological quality evaluation of systematic reviews or meta-analysis of trastuzumab-based therapy for breast cancer: A systematic review
por: Wei, Hua, et al.
Publicado: (2021)

Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis
por: Liu, Xu, et al.
Publicado: (2017)

Efficacy and safety of endocrine monotherapy as first-line treatment for hormone-sensitive advanced breast cancer: A network meta-analysis
por: Zhang, Jingwen, et al.
Publicado: (2017)

Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
por: Tao, Miaomiao, et al.
Publicado: (2017)

Induced abortion and breast cancer: An updated meta-analysis
por: Deng, Yongchun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1djepphlkp4g6ci3atnckt0pej